Cargando…
CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility
BACKGROUND: Impaired regulatory T cell immunity plays a central role in the development of type 1 diabetes (T1D). Interleukin-2 receptor (IL-2R) signaling is essential for regulatory T cells (T(REG)), and cytokine-inducible SH2-containing protein (CIS) regulates IL-2R signaling as a feedback inhibit...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801137/ https://www.ncbi.nlm.nih.gov/pubmed/29411179 http://dx.doi.org/10.1186/s40348-018-0080-7 |
_version_ | 1783298294751952896 |
---|---|
author | Seyfarth, Julia Ahlert, Heinz Rosenbauer, Joachim Baechle, Christina Roden, Michael Holl, Reinhard W. Mayatepek, Ertan Meissner, Thomas Jacobsen, Marc |
author_facet | Seyfarth, Julia Ahlert, Heinz Rosenbauer, Joachim Baechle, Christina Roden, Michael Holl, Reinhard W. Mayatepek, Ertan Meissner, Thomas Jacobsen, Marc |
author_sort | Seyfarth, Julia |
collection | PubMed |
description | BACKGROUND: Impaired regulatory T cell immunity plays a central role in the development of type 1 diabetes (T1D). Interleukin-2 receptor (IL-2R) signaling is essential for regulatory T cells (T(REG)), and cytokine-inducible SH2-containing protein (CIS) regulates IL-2R signaling as a feedback inhibitor. Previous studies identified association of CISH promoter region single nucleotide polymorphisms (SNPs) with susceptibility to infectious diseases. METHODS: Here we analyzed allele frequencies of three CISH SNPs (i.e., rs809451, rs414171, rs2239751) in a study of T1D patients (n = 260, onset age < 5 years, duration > 10 years). Minor allele frequencies were compared to a control cohort of the 1000 Genomes Project. Assigned haplotypes were determined for effects on T1D manifestation and severity. Finally, the CISH haplotype influence on cytokine signaling and function was explored in T cells from healthy donors. RESULTS: We detected similar minor allele frequencies between T1D patients and the control cohort. T1D onset age, residual serum C-peptide level, and insulin requirement were comparable between different haplotypes. Only minor differences between the haplotypes were found for in vitro cytokine (i.e., IL-2, IL-7)-induced CIS mRNA expression. STAT5 phosphorylation was induced by IL-2 or IL-7, but no differences were found between the haplotypes. T(REG) purified from healthy donors with the two most common haplotypes showed similar capacity to inhibit heterologous effector T cells. CONCLUSIONS: This study provides no evidence for an association of CISH promoter SNPs with susceptibility to T1D or severity of disease. In contrast to previous studies, no influence of different haplotypes on CIS mRNA expression or T cell-mediated functions was found. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40348-018-0080-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5801137 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-58011372018-02-13 CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility Seyfarth, Julia Ahlert, Heinz Rosenbauer, Joachim Baechle, Christina Roden, Michael Holl, Reinhard W. Mayatepek, Ertan Meissner, Thomas Jacobsen, Marc Mol Cell Pediatr Research BACKGROUND: Impaired regulatory T cell immunity plays a central role in the development of type 1 diabetes (T1D). Interleukin-2 receptor (IL-2R) signaling is essential for regulatory T cells (T(REG)), and cytokine-inducible SH2-containing protein (CIS) regulates IL-2R signaling as a feedback inhibitor. Previous studies identified association of CISH promoter region single nucleotide polymorphisms (SNPs) with susceptibility to infectious diseases. METHODS: Here we analyzed allele frequencies of three CISH SNPs (i.e., rs809451, rs414171, rs2239751) in a study of T1D patients (n = 260, onset age < 5 years, duration > 10 years). Minor allele frequencies were compared to a control cohort of the 1000 Genomes Project. Assigned haplotypes were determined for effects on T1D manifestation and severity. Finally, the CISH haplotype influence on cytokine signaling and function was explored in T cells from healthy donors. RESULTS: We detected similar minor allele frequencies between T1D patients and the control cohort. T1D onset age, residual serum C-peptide level, and insulin requirement were comparable between different haplotypes. Only minor differences between the haplotypes were found for in vitro cytokine (i.e., IL-2, IL-7)-induced CIS mRNA expression. STAT5 phosphorylation was induced by IL-2 or IL-7, but no differences were found between the haplotypes. T(REG) purified from healthy donors with the two most common haplotypes showed similar capacity to inhibit heterologous effector T cells. CONCLUSIONS: This study provides no evidence for an association of CISH promoter SNPs with susceptibility to T1D or severity of disease. In contrast to previous studies, no influence of different haplotypes on CIS mRNA expression or T cell-mediated functions was found. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40348-018-0080-7) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2018-02-06 /pmc/articles/PMC5801137/ /pubmed/29411179 http://dx.doi.org/10.1186/s40348-018-0080-7 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Seyfarth, Julia Ahlert, Heinz Rosenbauer, Joachim Baechle, Christina Roden, Michael Holl, Reinhard W. Mayatepek, Ertan Meissner, Thomas Jacobsen, Marc CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility |
title | CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility |
title_full | CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility |
title_fullStr | CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility |
title_full_unstemmed | CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility |
title_short | CISH promoter polymorphism effects on T cell cytokine receptor signaling and type 1 diabetes susceptibility |
title_sort | cish promoter polymorphism effects on t cell cytokine receptor signaling and type 1 diabetes susceptibility |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801137/ https://www.ncbi.nlm.nih.gov/pubmed/29411179 http://dx.doi.org/10.1186/s40348-018-0080-7 |
work_keys_str_mv | AT seyfarthjulia cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility AT ahlertheinz cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility AT rosenbauerjoachim cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility AT baechlechristina cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility AT rodenmichael cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility AT hollreinhardw cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility AT mayatepekertan cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility AT meissnerthomas cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility AT jacobsenmarc cishpromoterpolymorphismeffectsontcellcytokinereceptorsignalingandtype1diabetessusceptibility |